Entry Instance

HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "id": 597999,
    "url": "https://info.mzalendo.com/api/v0.1/hansard/entries/597999/?format=api",
    "text_counter": 149,
    "type": "speech",
    "speaker_name": "Sen. Kittony",
    "speaker_title": "",
    "speaker": {
        "id": 13110,
        "legal_name": "Zipporah Jepchirchir Kittony",
        "slug": "zipporah-jepchirchir-kittony"
    },
    "content": "Mr. Deputy Speaker, Sir, I have the supplementary information regarding the Statement to the Senate on the malaria outbreak in western Kenya and the inappropriate administration of the injectables in Busia County. This is the supplementary information requested as per the Senate HANSARD Report of 29th July, 2015. (1) Efficacy of Artemether Lumefantrine for the treatment of uncomplicated malaria. Through a collaborative effort with Kenya Medical Research Institute (KEMRI) and the Centre for Disease Control (CDC), the Ministry of Health conducts therapeutic efficacy trials every two years to check on the efficacy of anti-malarials. In 2014, data from two sites in high malaria burden areas (Kwale and Ahero) showed the efficacy to be 98 per cent. This is within the allowable limit for efficacy as set by the World Health Organisation (WHO). The management of malaria is carried out as per WHO guidelines and there are no plans to use Quinine for the management of uncomplicated malaria. (2) Inappropriate administration of an injection. We established that the injection of Artesunate was made to the wrong site but was not injected into the nerve trunk because all the children that were affected recovered. Out of the 21 children that were referred to the Nairobi Hospital for further management, all of them were discharged for follow up and rehabilitation at the county health facilities. It is expected that all children except one, will recover because it was partial paralysis. (3) Similar errors committed in other counties. No similar errors have been reported in other counties. The Ministry has been in communication with other counties on mitigation measures to avoid a repeat of the error. The measures proposed include the revitalization of County and Sub-County Therapeutic Committees and the strengthening of the supervision of health workers on procedures being used on patients. The counties have also been alerted on the need to report any adverse drug reactions whenever they appear to the Pharmacy and Poisons Board, Ministry of Health. (4) Qualification and training personnel who carry out injection procedures. Regarding qualification and training of personnel who carry out the procedures, we have established that personnel who gave the injection were trained to the level of Kenya Registered Community Health Nurse at diploma level. These officers were well qualified but probably lacked regular supervision on procedures and skills on injection administration. The Ministry has communicated to all counties on the need to enhance supervision. The Ministry has also issued guidelines and other relevant job aids to counties with the objective of ensuring that there is quality of procedures and that there is adherence to Standard Treatment Guidelines. (5) Use of dichlorodiphenyltrichloroethane (DDT) for mosquito control. Traditionally, the Ministry has used pyrethroids for Indoor Residual Spraying (IRS) for mosquito control. Concurrent with their use, their efficacy as being monitored and due to resistance problems, the Government has since shifted to organophosphates The electronic version of the Senate Hansard Report is for information purposes only. A certified version of this Report can be obtained from the Hansard Editor, Senate."
}